Who are Vayarin®, supplementation of n-3 PUFA's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): N-acetyl-D-glucosamine, Polyunsaturated Fatty Acids, Flax oil, Rubus occidentalis extract, Grape Seed Extract, HydroEye®.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/vayarin-supplementation-of-n-3-pufa.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Vayarin®, supplementation of n-3 PUFA — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vayarin®, supplementation of n-3 PUFA (Vayarin®, supplementation of n-3 PUFA) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: nutraceutical. Area: Neurology.

phase 3 nutraceutical Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Vayarin®, supplementation of n-3 PUFA (Vayarin®, supplementation of n-3 PUFA) — Hospices Civils de Lyon. Vayarin® provides a targeted delivery of n-3 polyunsaturated fatty acids (PUFAs) to support brain health and function.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Vayarin®, supplementation of n-3 PUFA TARGET	Vayarin®, supplementation of n-3 PUFA	Hospices Civils de Lyon	phase 3	nutraceutical
N-acetyl-D-glucosamine	N-acetyl-D-glucosamine	Third Military Medical University	marketed	Dietary supplement / Nutraceutical
Polyunsaturated Fatty Acids	Polyunsaturated Fatty Acids	Hadir F. El-Dessouky	marketed	Dietary supplement / Nutraceutical
Flax oil	Flax oil	University of Rochester	marketed	Dietary supplement / Nutraceutical
Rubus occidentalis extract	Rubus occidentalis extract	Korea University Anam Hospital	marketed	Botanical extract / Nutraceutical
Grape Seed Extract	Grape Seed Extract	Al-Azhar University	marketed	Botanical/nutraceutical antioxidant
HydroEye®	HydroEye®	University of Alabama at Birmingham	marketed	Nutritional supplement / Nutraceutical

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (nutraceutical class)

Hospices Civils de Lyon · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Vayarin®, supplementation of n-3 PUFA — Competitive Intelligence Brief. https://druglandscape.com/ci/vayarin-supplementation-of-n-3-pufa. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab